Anis Rageh Mohammed Al-Maleki

Prof. Dr. Anis Rageh Mohammed Al-Maleki

Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
orcid
Antimicrobial resistance, biofilms, and microbial omics | Dr...

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
GVGopinath Venkatraman
Gopinath Venkatraman
SSSaravannan Sekaran
Saravannan Sekaran
Anis Rageh Mohammed Al-MalekiAnis Rageh Mohammed Al-Maleki
Anis Rageh Mohammed Al-Maleki
MRM. Ramesh
M. Ramesh
JVJamuna Vadivelu
Jamuna Vadivelu

8 November 2016 in RSC Advances
Verified
Journal Article
Closed access
PDF file
GVGopinath Venkatraman
Gopinath Venkatraman
SPS. Priyadarshini
S. Priyadarshini
Anis Rageh Mohammed Al-MalekiAnis Rageh Mohammed Al-Maleki
Anis Rageh Mohammed Al-Maleki
MAM. Alagiri
M. Alagiri
RYRosiyah Yahya
Rosiyah Yahya
JVJamuna Vadivelu
Jamuna Vadivelu
Herein, copper oxide nanoparticles (CuONPs) are proposed for widespread use in emerging biomedical applications. The aim of this study is to synthesize and characterize CuONPs using the aqueous dried fruit extract of Tribulus terrestris and assess their potential in vitro cytotoxicity and antibacterial activity. The CuONPs bio-physical and morphological properties are characterized via different analytical techniques. The synthesized particles are highly stable and spherical with particle sizes in the range of 5–22 nm. Confocal microscopy reveals that ROS generation is the potent mechanism behind the role of CuONPs mediated antimicrobial toxicity. In addition, MTT and apoptotic analyses illustrate that the CuONPs are relatively cytofriendly toward human mesenchymal stem cells and also exhibit anti-cancer activity on human adenocarcinoma AGS cell lines. These results clearly indicate that the prepared copper oxide nanoparticles are safe and their application can be expanded as effectual antimicrobial and anticancer agents for pharmaceutical applications.

1 January 2013 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
LCLeang-Chung Choh
Leang-Chung Choh
GOGuang-Han Ong
Guang-Han Ong
KVKumutha Malar Vellasamy
Kumutha Malar Vellasamy
KKKaveena Kalaiselvam
Kaveena Kalaiselvam
WKWen-Tyng Kang
Wen-Tyng Kang
KVKumutha Malar Vellasamy
Kumutha Malar Vellasamy
The genus Burkholderia consists of diverse species which includes both ‘friends’ and ‘foes’. Some of the ‘friendly’ Burkholderia spp. are extensively used in the biotechnological and agricultural industry for bioremediation and biocontrol. However, several members of the genus including B. pseudomallei, B. mallei and B. cepacia, are known to cause fatal disease in both humans and animals. B. pseudomallei and B. mallei are the causative agents of melioidosis and glanders, respectively, while B. cepacia infection is lethal to cystic fibrosis patients. Due to the high rate of infectivity and intrinsic resistance to many commonly used antibiotics, together with high mortality rate, B. mallei and B. pseudomallei are considered to be potential biological warfare agents. Treatments of the infections caused by these bacteria are often unsuccessful with frequent relapse of the infection. Thus, we are at a crucial stage of the need for Burkholderia vaccines. Although the search for a prophylactic therapy candidate continues, to date development of vaccines has not advanced beyond research to human clinical trials. In this article, we review the current research on development of safe vaccines with high efficacy against B. pseudomallei, B. mallei and B. cepacia. It can be concluded that further research will enable elucidation of the potential benefits and risks of Burkholderia vaccines.

3 August 2017 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
Anis Rageh Mohammed Al-MalekiAnis Rageh Mohammed Al-Maleki
Anis Rageh Mohammed Al-Maleki
MLMun Fai Loke
Mun Fai Loke
SLSook Yin Lui
Sook Yin Lui
NRNur Siti Khadijah Ramli
Nur Siti Khadijah Ramli
YKYalda Khosravi
Yalda Khosravi
KVKumutha Malar Vellasamy
Kumutha Malar Vellasamy
Outer inflammatory protein A (OipA) is an important virulence factor associated with gastric cancer and ulcer development; however, the results have not been well established and turned out to be controversial. This study aims to elucidate the role of OipA in Helicobacter pylori infection using clinical strains harbouring oipA “on” and “off” motifs. Proteomics analysis was performed on AGS cell pre‐infection and postinfection with H. pylori oipA “on” and “off” strains, using liquid chromatography/mass spectrometry. AGS apoptosis and cell cycle assays were performed. Moreover, expression of vacuolating cytotoxin A (VacA) was screened using Western blotting. AGS proteins that have been suggested previously to play a role or associated with gastric disease were down‐regulated postinfection with oipA “off” strains comparing to oipA “on” strains. Furthermore, oipA “off” and ΔoipA cause higher level of AGS cells apoptosis and G0/G1 cell‐cycle arrest than oipA “on” strains. Interestingly, deletion of oipA increased bacterial VacA production. The capability of H. pylori to induce apoptosis and suppress expression of proteins having roles in human disease in the absence of oipA suggests that strains not expressing OipA may be less virulent or may even be protective against carcinogenesis compared those expressing OipA. This potentially explains the higher incidence of gastric cancer in East Asia where oipA “on” strains predominates.

1 June 2014 in Journal of Proteomics
Verified
Journal Article
Closed access
Anis Rageh Mohammed Al-MalekiAnis Rageh Mohammed Al-Maleki
Anis Rageh Mohammed Al-Maleki
VMVanitha Mariappan
Vanitha Mariappan
KVKumutha Malar Vellasamy
Kumutha Malar Vellasamy
ESEsaki Muthu Shankar
Esaki Muthu Shankar
STSun Tee Tay
Sun Tee Tay
KVKumutha Malar Vellasamy
Kumutha Malar Vellasamy

8 November 2017 in Journal of Applied Polymer Science
Verified
Journal Article
Closed access
PDF file
MRMuhammad Rizwan
Muhammad Rizwan
RYRosiyah Yahya
Rosiyah Yahya
AHAziz Hassan
Aziz Hassan
MYMuhammad Yar
Muhammad Yar
RORos Anita Omar
Ros Anita Omar
GVGopinath Venkatraman
Gopinath Venkatraman